TERT and cancer: The Cas9-based cancer therapy may further benefit from its multiplex targeting capacity, which enables simultaneous targeting multiple genes, for example telomerase genes (e.g., TERT), the ALT pathway genes, and other key ones to cancer cell survival pathways.